Watson-Marlow Announces Details of New U.S. Manufacturing Facility

29.10.2021
Watson-Marlow is pleased to announce that construction will start in October 2021, on a new state-of-the-art manufacturing facility in the United States, with first production due in late 2022.
Watson-Marlow Announces Details of New U.S. Manufacturing Facility

Watson-Marlow announces details of the new U.S. manufacturing facility bringing them closer to customers in the region. (Image source: Watson-Marlow Fluid Technology Group)

Following an announcement made earlier this year, the Company is pleased to provide further details about the new facility which will be dedicated to its range of industry leading products, including peristaltic pumps, tubing, fluid path solutions and BioPure components.

Part of Spirax-Sarco Engineering plc, a FTSE100 Company, Watson-Marlow specializes in high-quality fluid management solutions for the life sciences and process industries. This significant investment in the expansion of its manufacturing capacity will support the Company’s future growth in the Americas.

Located in Devens, Massachusetts, USA, the 150,000 square foot (14,000 square metres) facility will be close to the life sciences hub in the Cambridge/Boston area. The site will incorporate a suite of eight ISO14644-1 Class 7 cleanrooms, warehousing and offices, with space for two further cleanrooms within the initial footprint. With segregated cleanroom and non-cleanroom production capabilities, Watson-Marlow’s new U.S. facility will strengthen the support the Company provides to customers in the region across its core sectors of pharmaceutical and biotechnology, medical diagnostics, and process industries.

“The new U.S. facility is an important milestone in the Watson-Marlow company history and marks a significant commitment to serving our customers in the Americas region.” Says Andrew Mines, Watson-Marlow Managing Director, “This exciting development is bringing us closer to our customers whose purpose is to help the world around us, from advancing cell and gene therapies through to ensuring people have access to clean drinking water. Together we will continue to develop market-leading fluid management solutions to engineer a more sustainable future. A huge thanks goes to the Watson-Marlow, BioPure, Americas and Watson-Marlow Central Support teams that are making this happen, as well as to our parent Company, Spirax-Sarco Engineering who have enabled us to make such a significant investment in our future.”

Watson-Marlow is an award-winning employer and this new facility will bring significant job opportunities to the local area, with over 150 positions coming available. Production at the new facility will replicate that of Watson-Marlow’s European sites, ensuring continued product quality for customers, by using the same raw materials, components, processes and work instructions. Completion of the facility is due in late 2022, with the first products due to be shipped from the site in late Q4.

More articles on this topic

A Decade of Turbulence – Water in the US

29.07.2022 -

As technology and innovation consultancy Isle celebrates the 10-year anniversary of its presence in the US water market, Cristina Ahmadpour, Isle president and managing director (Americas), draws on the expertise of her team to reflect on the last decade in water and divines the critical drivers that will influence progress toward a sustainable and resilient water future.

Read more

Watson-Marlow Fluid Technology Solutions: Name Change Reflects Complete Fluid Management Solution Offering

12.04.2022 -

Watson-Marlow Fluid Technology Group – part of Spirax-Sarco Engineering plc, a FTSE 100 company – announces it has changed its name to Watson-Marlow Fluid Technology Solutions (WMFTS). As the company evolves to meet the needs of the sectors in which it operates, following a successful period of global growth, the name change aligns with a strategic commitment to providing end-to-end fluid management solutions for customers.

Read more